TY - JOUR
T1 - Antimicrobial stewardship barriers and goals in pediatric oncology and bone marrow transplantation
T2 - A survey of antimicrobial stewardship practitioners
AU - Wolf, Joshua
AU - Sun, Yilun
AU - Tang, Li
AU - Newland, Jason G.
AU - Gerber, Jeffrey S.
AU - Van Dyke, Christie J.
AU - Hymes, Saul R.
AU - Yu, Diana
AU - Carias, Delia C.
AU - Bryant, Penelope A.
N1 - Publisher Copyright:
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved.
PY - 2015/12/7
Y1 - 2015/12/7
N2 - Children undergoing cancer therapy or bone marrow transplantation (BMT) are at high risk of serious infection and receive frequent, prolonged courses of broad-spectrum antimicrobial agents.1,2 Although some antimicrobial exposure is appropriate, usage in many cases is inconsistent with evidencebased guidelines and results in significant toxicity, resistance, antibiotic-associated infections, and financial cost.3-6 Many institutions have attempted to optimize antimicrobial prescribing by implementing antimicrobial stewardship programs (ASPs).7,8 However, little is known about the main antimicrobial stewardship goals, current interventions, or barriers to those interventions in this group. Proposed barriers include insufficient time-allocation or expertise; patient complexity; and perceptions or attitudes of oncology physicians1,2,9 but these have not been examined in pediatric oncology. We addressed this knowledge gap by conducting a survey assessing the goals and perceived barriers for ASP clinicians practicing in pediatric hematology and oncology.
AB - Children undergoing cancer therapy or bone marrow transplantation (BMT) are at high risk of serious infection and receive frequent, prolonged courses of broad-spectrum antimicrobial agents.1,2 Although some antimicrobial exposure is appropriate, usage in many cases is inconsistent with evidencebased guidelines and results in significant toxicity, resistance, antibiotic-associated infections, and financial cost.3-6 Many institutions have attempted to optimize antimicrobial prescribing by implementing antimicrobial stewardship programs (ASPs).7,8 However, little is known about the main antimicrobial stewardship goals, current interventions, or barriers to those interventions in this group. Proposed barriers include insufficient time-allocation or expertise; patient complexity; and perceptions or attitudes of oncology physicians1,2,9 but these have not been examined in pediatric oncology. We addressed this knowledge gap by conducting a survey assessing the goals and perceived barriers for ASP clinicians practicing in pediatric hematology and oncology.
UR - http://www.scopus.com/inward/record.url?scp=84959252073&partnerID=8YFLogxK
U2 - 10.1017/ice.2015.295
DO - 10.1017/ice.2015.295
M3 - Article
C2 - 26639441
AN - SCOPUS:84959252073
SN - 0899-823X
VL - 37
SP - 343
EP - 347
JO - Infection Control and Hospital Epidemiology
JF - Infection Control and Hospital Epidemiology
IS - 3
ER -